729
Views
0
CrossRef citations to date
0
Altmetric
Comment

Burgeoning rise in intraductal papillary mucinous neoplasia (IPMN) – a blessing in disguise

ORCID Icon
Pages 1101-1104 | Received 24 Feb 2023, Accepted 23 Mar 2023, Published online: 06 Apr 2023

References

  • Zhu S, Wang WT, Shang XS, et al. Difference analysis in prevalence of incidental pancreatic cystic lesions between computed tomography and magnetic resonance imaging. BMC Med Imaging. 2019;19(1):43.
  • Kromrey ML, Bülow R, Hübner J, et al. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut. 2018;67(1):138–145.
  • Salvia R, Marchegiani G. Evolving management of pancreatic cystic neoplasms. Br J Surg. 2020;107(11):1393–1395.
  • Søreide K, Marchegiani G. Clinical management of pancreatic premalignant lesions. Gastroenterology. 2022;162(2):379–384.
  • Aziz H, Acher AW, Krishna SG, et al. Comparison of society guidelines for the management and surveillance of pancreatic cysts: a review. JAMA Surg. 2022;157(8):723–730.
  • Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226(3):248–257. discussion 257–260.
  • Borgne L, de Calan J, Partensky L. C. Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French surgical association. Ann Surg. 1999;230(2):152–161.
  • Meyer W, Köhler J, Gebhardt C. Cystic neoplasms of the pancreas–cystadenomas and cystadenocarcinomas. Langenbecks Arch Surg. 1999;384(1):44–49.
  • Bendix Holme J, Jacobsen NO, Rokkjaer M, et al. Total pancreatectomy in six patients with intraductal papillary mucinous tumour of the pancreas: the treatment of choice. HPB (Oxford). 2001;3(4):257–262.
  • Røsok BI, Rosseland AR, Grzyb K, et al. Laparoscopic resection of an intraductal papillary mucinous carcinoma in ectopic pancreatic tissue. J Laparoendosc Adv Surg Tech A. 2008;18(5):723–725.
  • Dongbin L, Fei L, Werner Josefin B, et al. Intraductal papillary mucinous neoplasms of the pancreas: diagnosis and management. Eur J Gastroenterol Hepatol. 2010;22(9):1029–1038.
  • Ånonsen K, Sahakyan MA, Kleive D, et al. Trends in management and outcome of cystic pancreatic lesions - analysis of 322 cases undergoing surgical resection. Scand J Gastroenterol. 2019;54(8):1051–1057.
  • Aronsson L, Andersson B, Andersson R, et al. Intraductal papillary mucinous neoplasms of The pancreas: a nationwide Registry-Based study. Scand J Surg. 2018;107(4):302–307.
  • Loftus EV, Jr., Olivares-Pakzad BA, Batts KP, et al. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the pancreas clinic, and pancreatic surgeons of Mayo clinic. Gastroenterology. 1996;110(6):1909–1918.
  • Sarr MG, Carpenter HA, Prabhakar LP, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg. 2000;231(2):205–212.
  • Sarr MG, Kendrick ML, Nagorney DM, et al. Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. Surg Clin North Am. 2001;81(3):497–509.
  • Adsay NV. The "new kid on the block": intraductal papillary mucinous neoplasms of the pancreas: current concepts and controversies. Surgery. 2003;133(5):459–463.
  • Wilentz RE, Iacobuzio-Donahue CA, Argani P, et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 2000;60(7):2002–2006.
  • Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25(5):579–586.
  • Day JD, Digiuseppe JA, Yeo C, et al. Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum Pathol. 1996;27(2):119–124.
  • Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994;425(4):357–367.
  • Islam HK, Fujioka Y, Tomidokoro T, et al. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas. Hepatogastroenterology. 2001;48(39):879–883.
  • Klein WM, Hruban RH, Klein-Szanto AJ, et al. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression. Mod Pathol. 2002;15(4):441–447.
  • Søreide K, Immervoll H, Molven A. [Precursors to pancreatic cancer. ]. Tidsskr Nor Laegeforen. 2006;126(7):905–908.
  • Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28(8):977–987.
  • Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg. 2001;234(3):313–321. discussion 321–312.
  • Aunan JR, Jamieson NB, Søreide K. Observation or resection of pancreatic intraductal papillary mucinous neoplasm: an ongoing tug of war. World J Gastrointest Oncol. 2019;11(12):1092–1100.
  • Zelga P, Hernandez-Barco YG, Qadan M, et al. C. Number of worrisome features and risk of malignancy in intraductal papillary mucinous neoplasm. J Am Coll Surg. 2022;234(6):1021–1030.
  • Roldán J, Harrison JM, Qadan M, et al. Evolving trends in pancreatic cystic tumors: a 3-Decade Single-Center experience With 1290 resections. Ann Surg. 2023;277(3):491–497.
  • McIntyre CA, Rodrigues C, Santharaman AV, et al. Multiinstitutional validation study of cyst fluid protein biomarkers in patients With cystic lesions of the pancreas. Ann Surg. 2022;276(2):e129–e132.
  • Springer S, Masica DL, Dal Molin M, et al. A multimodality test to guide the management of patients with a pancreatic cyst. Sci Transl Med. 2019;11(501):eaav4772.
  • Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3(92):92ra66.
  • McCarty TR, Paleti S, Rustagi T. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93(5):1019–1033.e5. e1015.
  • Søreide K, Ismail W, Roalsø M, et al. Early diagnosis of pancreatic cancer: clinical premonitions, timely precursor detection and increased Curative-Intent surgery. Cancer Control. 2023;30:107327482311547.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.